Trademarkia Logo

Australia

AU$
Trademark Search
RELEVANT

View On IPO.GOV.AU

RELEVANT
Cancelled: Cancelled at the request of IB

Last updated on 2 Jul 2015

Owner Info

Celgene Corporation

86 Morris Avenue

Summit, NJ 07901, UNITED STATES OF AMERICA

Serial Number

1437848 filed on 2 Jun 2011

Correspondent

Camille M. Miller Cozen O'Connor, PC

1900 Market Street,

Philadelphia PA 19103,

UNITED STATES OF AMERICA

RELEVANT

Classification Information

Class [042]
Medical and scientific research being the conducting of clinical trials for testing the safety and effectiveness of rituximab and lenalidomide

Mark Details

Serial Number

1437848

Registered On

2 Jun 2011

Renewal On

NA

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
2th Jul 2015Cancellation of Entry in Register Published
26th Jun 2015Cancel IP Right
13th Nov 2014General Correspondence (Application or Registration)
30th May 2013IP Right Registration Published
22nd May 2013Register Trade Mark
22nd May 2013Application Status
14th Feb 2013IP Right Acceptance Published
6th Feb 2013Clear Examination report approved
6th Feb 2013Application Accepted correspondence sent
5th Feb 2013Goods and Services Classes